Related Experiment Video
Updated: Jun 9, 2026

08:17
A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
Published on: February 27, 2018
Role of interleukin-1beta in postoperative cognitive dysfunction.
Mario Cibelli1, Antonio Rei Fidalgo, Niccolò Terrando
1Department of Anesthetics, Pain Medicine, and Intensive Care, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom.
Annals of Neurology
|September 7, 2010
Summary
Surgery triggers inflammation in the brain, causing memory loss in mice. Blocking interleukin-1 beta (IL-1β) with targeted treatments prevented this postoperative cognitive dysfunction.
Area of Science:
- Neuroscience
- Immunology
- Surgical Research
Background:
- Postoperative cognitive dysfunction (POCD) is a common complication after major surgery.
- The underlying mechanisms of POCD, particularly the role of inflammation, are not fully understood.
Purpose of the Study:
- To investigate if systemic inflammation from surgical trauma causes hippocampal inflammation and memory deficits in a mouse model.
- To explore the role of interleukin-1 beta (IL-1β) in surgery-induced cognitive impairment.
Main Methods:
- Orthopedic surgery was performed on C57BL/6J mice, including wild-type and IL-1 receptor knockout (IL-1R(-/-)) strains.
- Memory function was assessed using fear conditioning tests.
- Systemic and hippocampal cytokines and microglial activation were measured.
- The effects of anti-inflammatory interventions were evaluated.
Main Results:
- Surgery led to memory impairment, increased plasma cytokines, and hippocampal inflammation (microgliosis, IL-1β).
- Minocycline, an anti-inflammatory agent, prevented surgery-induced cognitive and neuroinflammatory changes.
- Blocking IL-1β activity, via IL-1 receptor antagonist or in IL-1R(-/-) mice, reduced neuroinflammation and memory dysfunction.
Conclusions:
- Peripheral surgery-induced inflammation triggers an IL-1β-mediated hippocampal inflammatory response, causing memory impairment.
- Targeting IL-1β may be a potential therapeutic strategy to prevent POCD.